Hepatitis C virus infection diagnosis using metabonomics

Journal of Viral Hepatitis

Volumn 17, Issue 12, 2010, Pages 854-858

  Godoy, M M G ^a   Lopes, E P A ^a   Silva, R O ^b   Hallwass, F ^b   Koury, L C A ^a   Moura, I M ^a   Goncalves S M C ^b   Simas, A M ^b  

^a Federal University of Pernambuco   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

1H NMR; HCV; hepatitis C; metabonomics; spectroscopy

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; METABONOMICS; MODEL; PILOT STUDY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; URINE;

EID: 78649309778     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01252.x     Document Type: Article

References (35)

1. Alter MJ,. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13: 2436 - 2441.
2. Sherman M, Shafran S, Burak K, et al. Management of chronic hepatitis C: consensus guidelines. Can J Gastroenterol 2007; 21: 25C - 34C. (Pubitemid 47177083)
3. Davis GL, Albright JE, Cook SF, Rosenberg DM,. Projecting future complications of chronic hepatitis C in the United States. Liver Tranpl 2003; 9: 331 - 338.
4. Seeff LB, Miller RN, Rabkin CS, et al. 45-Year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105 - 111.
5. Lauer GM, Walker BD,. Medical progress: hepatitis C virus infection. N Engl J Med 2001; 345: 41 - 52.
6. Seeff LB,. The history of the "natural history" of hepatitis. Liver Int 2009; 29: 89 - 99.
7. Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998; 28: 1687 - 1695.
8. Alter HJ, Seeff LB,. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000; 20: 17 - 35.
9. Lopes EPA, Granato CH, Lanzoni V, et al. Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome. Mem Inst Oswaldo Cruz 2000; 95: 717 - 720.
10. Gretch DR,. Diagnostic tests for hepatitis C. Hepatology 1997; 26: 43S - 47S.
11. Ferreira-Gonzalez A, Shiffman ML,. Use of diagnostic testing for managing hepatitis C virus infection. Semin Liver Dis 2004; 24: 9 - 18.
12. Pawlotsky JM, Lonjon I, Hézode C, et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27: 1700 - 1702.
13. Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN,. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722 - 724.
14. Robertson DG,. Metabonomics in toxicology: a review. Toxicol Sci 2005; 85: 809 - 822.
15. Lindon JC, Nicholson JK, Holmes E, Everett JR,. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn Reson 2000; 12: 289 - 320.
16. Robertson DG, Reily MD, Singler RE, Wells DF, Paterson DA, Braden TK,. Metabonomics: evaluation of NMR and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 2000; 57: 326 - 337.
17. Nicholson JK, Connelly J, Lindon JC, Holmes E,. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discover 2002; 1: 153 - 161.
18. Moyec LL, Racine S, Toumelin PL, et al. Aminoglycoside and glycopeptide renal toxicity in intensive care patients studied by proton magnetic resonance spectroscopy of urine. Crit Care Med 2002; 6: 1242 - 1245.
19. 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 2003; 128: 32 - 36.
20. Mäkinen VP, Soininen P, Forsblom C, et al. Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. Magn Reson Mater Phy 2006; 19: 281 - 296.
21. Marchesi JR, Holmes E, Khan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007; 6: 546 - 551.
22. Weljie AM, Dowlatabadi R, Miller BJ, Vogel HJ, Jirik FR,. An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. J Proteome Res 2007; 6: 3456 - 3464.
23. Coen M, O'Sullivan M, Bubb WA, Kuchel PW, Sorrel T,. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin Infect Dis 2005; 41: 1582 - 1590.
24. Lindon JC, Holmes E, Nicholson JK,. Pattern recognition methods and applications in biomedical magnetic resonance. Prog NMR Spectroscopy 2001; 39: 1 - 40.
25. Keun HC,. Metabonomic modeling of drug toxicity. Pharm Therap 2006; 109: 92 - 106.
26. Coen M, Holmes E, Lindon JC, Nicholson JK,. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008; 21: 9 - 27.
27. Lindon JC, Holmes E, Nicholson JK,. So what's the deal with metabonomics? Anal Chem 2003; 75: 384A - 391A.
28. Odunsi K, Wollman RM, Ambrosone CB, et al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer 2005; 113: 782 - 788.
29. Holmes E, Tsang TM, Tabrizi SJ,. The application of NMR-based metabonomics in neurological disorders. NeuroRx 2006; 3: 358 - 372.
30. Wang Y, Holmes E, Nicholson JK, et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci 2004; 101: 12676 - 12681.
31. 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals. Pharm Biom Anal 2006; 41: 1442 - 1446.
32. Nicholson JK, Lindon JC, Holmes E,. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181 - 1189.
33. 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 2003; 33: 1103 - 1115.
34. 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal 2004; 36: 841 - 849.
35. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E,. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 2005; 18: 143 - 162.